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Ppeak-Tend and Tpeak-Tend Dispersion
s Risk Factors for Ventricular Tachycardia/
entricular Fibrillation in Patients With the Brugada Syndrome
esus Castro Hevia, MD,* Charles Antzelevitch, PHD, FACC,† Francisco Tornés Bárzaga, MD,*
argarita Dorantes Sánchez, MD,* Francisco Dorticós Balea, PHD,* Roberto Zayas Molina, MD,*
iguel A. Quiñones Pérez, MD,* Yanela Fayad Rodríguez, MD*
avana, Cuba; and Utica, New York
OBJECTIVES Our objective in this study was to evaluate Tpeak-Tend interval (Tp-e) and other electrocardio-
graphic parameters as risk factors for recurrence of life-threatening cardiac events in patients with
the Brugada syndrome (BS).
BACKGROUND The Tp-e interval in the electrocardiogram (ECG) has been reported to predict life-
threatening arrhythmias in the long QT syndrome.
METHODS Twenty-nine patients with the ECG pattern of BS and 29 healthy age- and gender-matched
controls were studied. The follow-up period was 42.65  24.42 months (range 11 to 108
months).
RESULTS Upon presentation, five patients had suffered aborted sudden death, five syncope, and two
presyncope. Eleven patients with the ECG pattern of BS had a prolonged (460 ms) QTc
in V2 but usually not in inferior or left leads. No patient had abnormally prolonged QT
dispersion. Programmed electrical stimulation induced ventricular tachycardia/fibrillation in 5
out of 26 patients. Inducibility did not predict recurrence of events. Cardioverter-defibrillators
were implanted in 14 patients (all symptomatic and two asymptomatic). During follow-up,
nine symptomatic patients experienced recurrences. Previous cardiac events and a QTc 460
ms in V2 were significant risk factors (p  0.00002 and p  0.03, respectively). Tp-e and
Tp-e dispersion were significantly prolonged in patients with recurrences versus patients
without events (104.4 and 35.6 ms vs. 87.4 and 23.2 ms; p  0.006 and p  0.03,
respectively) or controls (90.7 and 17.9 ms; p  0.02 and p  0.001, respectively).
CONCLUSIONS Our study demonstrates significant correlation between previous events, QTc460 ms in V2,
Tp-e, and Tp-e dispersion and occurrence of life-threatening arrhythmic events, suggesting
that these parameters may be useful in risk stratification of patients with the Brugada
syndrome. (J Am Coll Cardiol 2006;47:1828–34) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.12.049Cardiology Foundation
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Q
drugada syndrome (BS) is characterized by a coved-type
T-segment elevation in leads V1 to V3 of the electrocar-
iogram (ECG) and a high incidence of sudden cardiac
eath or syncope secondary to ventricular tachycardia (VT)/
entricular fibrillation (VF) in structurally normal hearts (1).
isk stratification is controversial, especially in asymptom-
tic individuals (2–4). Among the recently reported risk
actors associated with VT/VF are a spontaneous coved-type
T-segment elevation, male gender, history of syncope or
borted sudden death, and programmed electrical stimulation
PES)-induced VT/VF (5). The present study was designed to
xamine the Tpeak-Tend interval (Tp-e) and Tp-e dispersion
s risk factors for arrhythmic events in BS patients.
ETHODS
etween November 1995 and February 2004, we enrolled
9 consecutive patients (4 female, 12 symptomatic, mean
From the *Arrhythmia Unit, Cardiovascular Surgery and Cardiology Institute,
avana, Cuba; and the †Masonic Medical Research Laboratory, Utica, New York.
upported by grants from the National Institutes of Health (HL 47678), the American
eart Association Northeast Affilitate, New York State, and Florida Grand Lodges F &
M.i
Manuscript received September 19, 2005; revised manuscript received November
4, 2005, accepted December 13, 2005.ge 42.3  12.2 years) referred to the Arrhythmia Unit and
iagnosed with ECG pattern of Brugada syndrome (Table
) and 29 healthy age-matched subjects for the purpose of
omparison of ECG parameters. The study was approved by
he ethical committee of the Cardiovascular Surgery and
ardiology Institute, Havana, Cuba. Clinical history, ECG,
nd echocardiogram were performed in all patients. Pro-
rammed electrical stimulation was carried out in all asymp-
omatic and nine symptomatic patients with the ECG
attern of BS in one or more right precordial leads. We used
standard PES protocol in the first nine patients: three
ycle length basic (600, 500, and 400 ms) and three extra
timuli from the right ventricular apex, with coupling
nterval not 200 ms, and used the protocol suggested in
he recent consensus report (6) in all other patients.
Pharmacologic challenge with intravenous ajmaline (1
g/kg body weight) or procainamide (10 mg/kg body
eight) was performed in 7 symptomatic and 11 asymp-
omatic patients who did not display the ECG pattern of BS
n more than one lead at the time of PES. The QT, QTc,
T dispersion, Tp-e, and Tp-e dispersion (defined as the
ifference between the maximum and minimum Tp-e
nterval in the precordial leads V1 to V6 during a single beat)
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May 2, 2006:1828–34 Risk Stratification in the Brugada Syndromeere manually measured. The ECG was recorded with a
tandard digital recorder as 12 simultaneous leads at a paper
peed of 25 mm/s. The QTc was obtained using Bazett’s
ormula (7). The QT interval was measured from the
eginning of the QRS to the end of T-wave, defined as the
ntersection of the tangent to the downslope of the T-wave
nd the isoelectric line (8). The QT dispersion was defined
s the difference between the maximum and minimum QT
nterval of the 12 leads (9). The Tp-e was measured in each
recordial lead and obtained from the difference between
T interval and QTpeak interval; measured from the begin-
ing of the QRS until the peak of the T-wave (Fig. 1). In
Abbreviations and Acronyms
AP  action potential
BS  Brugada syndrome
ECG  electrocardiogram
ICD  implantable cardioverter-defibrillator
LQTS  long QT syndrome
PES  programmed electrical stimulation
ROC  receiver-operating characteristic
TDR  transmural dispersion of repolarization
Tp-e  Tpeak-Tend interval
VF  ventricular fibrillation
VT  ventricular tachycardia
able 1. Clinical Characteristics of 29 Consecutive Patients Iden
atient # Inducible Symptomatic
Age
(yrs) Gender
1-JCB No Yes 45 Male
2-LSR — Yes 36 Male
3-NLC No Yes 33 Male
4-MGC Yes Yes 47 Male
5-OGC Yes Yes 37 Male
6-RMA No Yes 29 Male
7-JMR — Yes 49 Male
8-ARL No Yes 47 Male
9-GRA — Yes 37 Male
10-PGP No Yes 44 Male
11-GPT Yes Yes 53 Male
12-RRG No Yes 46 Male
13-JLLS No No 35 Male
14-EGT No No 27 Male
15-GMH Yes No 38 Male
16-RHG No No 51 Male
17-PBL No No 58 Male
18-RMV No No 34 Male
19-DCC Yes No 59 Female
20-MFS No No 28 Female
21-OPG No No 61 Female
22-EGC No No 36 Male
23-RPA No No 56 Male
24-NRJ No No 44 Male
25-FMH No No 39 Male
26-GPB No No 27 Male
27-ADB No No 20 Male
28-LBM No No 22 Female
29-EQM No No 68 Maleatient #26 is the son of Patient #11. Patients #11, #23, and #27 had heart rates 100 be
Tp-e  Tpeak-Tend interval.he case of negative or biphasic T waves, QTpeak was
easured to the nadir of the T-wave. T waves smaller than
.5 mm in amplitude were not measured. The Tp-e value
eported was the maximum obtained by two observers in all
recordial leads.
The measurement of each parameter was obtained by
veraging three consecutive beats. Two independent experts
btained the measurements and in case of a difference of
20 ms in each measurement, an agreement was obtained
r a third expert was recruited.
The end point of the study was clinical (syncope, aborted
udden death) and/or documented VT/VF. Follow-up of
atients with BS consisted of two visits per year, during which
n ECG was performed and the implantable cardioverter-
efibrillator (ICD) checked; most patients with BS-pattern
CG were contacted only by telephone, whereas some were
ore closely followed. The control group did not have
ollow-up.
tatistics. Categorical variables were compared using chi-
quared test. Group differences were analyzed by one-way
NOVA followed by Scheffé’s multiple comparison test.
umeric variables were compared using dependent-samples
test. To examine prognostic value from Tp-e and Tp-e
ispersion and determine cutoff values, analysis of receiver-
perating characteristic (ROC) curves were made according
With the Brugada Syndrome Electrocardiogram
c
II
s)
QTc
V2
(ms)
QTc
V5
(ms)
Tp-e
Interval
(ms)
Tp-e
Dispersion
(ms)
QT
Dispersion
(ms)
0 380 380 80 20 20
1 401 401 120 20 40
4 475 — 120 40 60
9 492 469 80 20 40
7 492 469 100 40 60
5 458 425 100 40 40
9 492 447 120 40 60
0 380 400 80 20 40
1 490 441 120 60 40
8 438 415 100 40 20
3 487 433 80 20 40
2 402 380 80 20 40
0 360 360 80 20 20
2 415 392 80 20 20
9 389 389 80 20 20
0 380 380 80 20 20
9 454 389 100 20 60
2 441 392 80 20 40
9 514 469 100 20 40
2 447 402 100 20 60
0 400 400 100 20 20
7 416 416 80 20 20
2 471 442 80 20 20
5 452 405 80 20 40
7 492 447 120 60 60
0 440 400 80 20 40
9 490 439 80 20 40
6 441 416 80 40 20
4 531 484 100 20 40tified
QT
Lead
(m
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Risk Stratification in the Brugada Syndrome May 2, 2006:1828–34o standard procedures (10). Kaplan-Meier survival curves
ere plotted, and log rank test was used to compare the
urves. Data are expressed as mean  SD. A value of p 
.05 was considered statistically significant.
ESULTS
able 1 presents the clinical characteristics of the 29
onsecutive patients in which a BS-pattern ECG was
dentified. Fifteen patients were classified as BS, 12 of them
ymptomatic (5 aborted sudden death, 5 syncope, and 2
re-syncope) and 3 asymptomatic (VT/VF was induced in
, and 1 was the son of a symptomatic BS patient). Eight
ymptomatic patients displayed a type 1 basal ECG in more
han one lead and two in one lead, and two displayed a
ormal basal ECG; one asymptomatic patient had a type 1
asal ECG in more than one lead, one displayed a coved-
ype basal ECG in one lead but with a J point elevation of
2 mV, and another had type 1 basal ECG but only in one
ead.
With regard to BS-pattern ECG, eight displayed a type
basal ECG in more than one lead and five in only one
igure 1. Precordial leads of the electrocardiogram (ECG) of a patient
ith the Brugada syndrome with recurrences (A), a Brugada-type ECG
B), and a control case (C). Numbers depict measured values for QT,
Tpeak (QTp) and Tpeak-Tend interval (Tp-e). All values are in ms. T
aves 1.5 mm were not measured.ead, and one had a coved-type basal ECG in one lead but Iith a J point elevation of 2 mV. No patient displayed
bnormally prolonged QT dispersion.
A pharmacologic challenge was performed in nine BS
atients, seven of them symptomatic and two asymptomatic.
ll tested patients displayed a type 1 ECG in at least two
eads following challenge with a sodium-channel blocker.
hus, all BS patients displayed a type 1 ECG in at least two
eads with or without drugs, except one patient who had
ype 1 ECG in one lead and in whom the pharmacologic
est was not performed.
Pharmacologic challenge was performed in nine patients
ith a BS-pattern ECG; seven displayed a type 1 ECG in
ore than one lead, and two had a type 1 ECG in only one
ead.
Seven patients with BS and four with BS-type ECG had
maximal QTc 460 ms (Table 2). The longest QT and
Tc values measured under basal conditions (maxQT and
axQTc) were observed in V2 in 27 and in lead II in 2 of
he 29 patients with a type I ECG. In the presence of
odium-channel blockers, the longest QT and QTc values
ere observed in V2 in 29 out of 29 patients. In contrast, the
ongest QT and QTc was typically observed in lead II in
ontrols. Among the patients in which a sodium-channel
lock test was performed, QT and QTc values were greater
n the right precordial leads (V2) than in the inferior (II) or
eft precordial (V5) leads before challenge with a sodium-
hannel blocker, and this difference was further pronounced
fter drug (Table 3).
Ventricular tachycardia/ventricular fibrillation was in-
uced in five patients (three symptomatics). Cardioverter-
efibrillators were implanted in 14 patients (all 12 of the
ymptomatic and 2 of the asymptomatic patients). No
tatistically significant association was found between in-
ucibility and recurrence of VT/VF. Positive predictive
alue of PES induction of VT/VF was 60%, and negative
redictive value was 85.7%.
Of the symptomatic patients, nine suffered a recurrence
uring the follow-up period; polymorphic VT and/or VF
as detected and converted by appropriate discharge of the
CD. The occurrence of previous events was a highly
ignificant risk factor (p  0.00002) (Table 4). QTc 460
s in V2 was also a risk factor for recurrences (p  0.03)
Table 5). Most of the recurrences (55.5%) were in patients
ith a spontaneous type 1 ECG in more than one lead, a
axQTc 460 ms, and an average value of Tp-e 100 ms
Tables 1 and 2).
The Tp-e and Tp-e dispersion were significantly longer
n patients experiencing a recurrence compared with those
ho did not (104.4 and 35.6 ms vs. 87.4 and 23.2 ms; p 
.006 and p  0.03; respectively) as well as compared with
ontrols (90.7 and 17.9 ms; p  0.02 and p  0.001;
espectively) (Figs. 2 to 5). As indicated by the Kaplan-
eier curves displaying cumulative event-free survival, all
S patients with Tp-e values 100 ms or Tp-e dispersion
alues 20 ms had events during 60 months of follow-up.
n contrast, only 30% of BS patients with Tp-e 100 ms or
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May 2, 2006:1828–34 Risk Stratification in the Brugada Syndromep-e dispersion 20 ms had events during 60 months of
ollow-up. The areas under the ROC curves for Tp-e and
p-e dispersion were 0.788 and 0.772, respectively; indi-
ating that these variables are relatively good discriminators
f patients likely to develop life-threatening arrhythmic
vents.
ISCUSSION
ransmural dispersion of the repolarization within the
entricular myocardium has been suggested to underlie
rrhythmogenesis in Brugada, short QT, and long QT
yndromes (11). Three electrophysiologically distinct cell
ypes have been identified in the ventricular myocardium:
ndocardial, epicardial, and M cells. Differences in the time
ourse of repolarization of these three ventricular myocardial
ell types contribute prominently to inscription of the
lectrocardiographic T-wave (12). In isolated ventricular
edge preparations, the peak of the T-wave was shown to
oincide with epicardial repolarization and the end of the
-wave with repolarization of the M cells, so that Tp-e
able 3. Effect of Sodium-Channel Blocker Challenge on QT
nd QTc
Leads n
QTc Before
Test
(Mean  SD)
QTc After
Test
(Mean  SD) Statistics*
II 17 416.7  27.5 445.7  92.0 p  0.2
V2 18 433.3  40.0 511.7  42.0 p  0.0000001
V5 17 393.5  77.3 461.1  31.5 p  0.006
able 2. Electrocardiographic Parameters
maxQT maxQTc
ontrol
Asymptomatic
maxQTc 460 369  24.4 404  24.8
maxQTc 460 0 0
S-type ECG
Asymptomatic
maxQTc 460 382  28.9 436  19.5
maxQTc 460* 390  52.9 488  12.2
S patients (spontaneous type 1 ECG in more than one lead)
Symptomatic
maxQTc 460 367  11.5 418  9.8
maxQTc 460 416  32.8 479  11.4
Asymptomatic
maxQTc 460 0 0
maxQTc 460 440  0.0 492  0.0
S patients (sodium-channel blocker induced type 1 ECG in more than
Symptomatic
maxQTc 460 395  7.0 403  18.4
maxQTc 460† 440  0.0 492  0.0
Asymptomatic
maxQTc 460 390  42.4 411  12.7
maxQTc 460 0 0
ll values are in ms. maxQT and maxQTc represent the longest QT and QTc inter
spontaneous type 1 ECG in one lead and the pharmacologic test was not performe
one symptomatic Brugada patient had heart rate 100 beats/min at time of ECG
BS  Brugada syndrome; ECG  electrocardiogram; Tp-e  Tpeak-Tend interll values are in ms. *t test for dependent samples. Srovides a measure of transmural dispersion of repolariza-
ion (TDR) (13). These and other studies have suggested
hat although Tp-e on the surface ECG may not be
bsolutely equivalent to TDR, this interval may provide an
ndex of TDR and thus be helpful in forecasting risk for the
evelopment of life-threatening arrhythmias (12,14–17).
vidence in support of this hypothesis has been provided
nder hypertrophic cardiomyopathy, congenital and ac-
uired long QT, and other pathophysiologic conditions
12,14–18). To our knowledge, Tp-e has not been evalu-
ted as a risk factor in patients with BS.
Because of the paucity of studies involving large popula-
ions, there is no clear consensus as to normal values for
p-e. The present study examined this parameter in pa-
ients with the BS together with another parameter, Tp-e
ispersion. While Tp-e provides an index of the maximum
ispersion of repolarization, Tp-e dispersion reflects varia-
ion of the transmural dispersion of the repolarization
mong different regions of the ventricular myocardium. Our
tudy demonstrates a significant correlation between Tp-e
nd Tp-e dispersion and occurrence of life-threatening
rrhythmic events in patients with BS, suggesting that these
able 4. Association Between Previous and New Arrhythmic
vents
New Events No Events Totals
revious events 9 3 12
o events 0 17 17
otals 9 20 29
Tp-e
Tp-e
Dispersion
Cardiac Events
or Recurrences Total
 12.7 18  12.6 0 29
0 0 0 0
 10.0 22  6.3 0 10
 19.1 30  20 0 4
 11.5 33  11.5 2 3
 17.8 40  14.1 5 5
0 0 0 0
 0.0 20  0.0 0 1
ad)
 0.0 20  0.0 0 2
 0.0 20  0.0 1 1
 0.0 20  0.0 0 2
0 0 0 0
any of the 12 leads (usually in V2). One BS patient (who suffered recurrences) had
: 440; QTc: 401; Tp-e: 120; Tp-e dispersion: 20. *Two asymptomatic patients and
rement.91
87
95
93
108
100
one le
80
80
80
vals in
d. QTtatistics: Pearson chi-square p  0.00002.
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Risk Stratification in the Brugada Syndrome May 2, 2006:1828–34arameters may be useful in risk stratification of patients
ith BS.
The Tp-e was 19.6% greater and Tp-e dispersion 53.7%
reater in BS patients who experienced recurrences of
T/VF. Interestingly, these parameters were not signifi-
antly different between normal and BS patients without
ecurrences. The longest Tp-e was measured in lead V2 and
as due to marked abbreviation of QTpeak interval in this
ead. The latter is likely due to a briefer epicardial action
otential (AP) in this region of the right ventricle (RV),
hich in turn may be due to the proximity of this region to
hat at which loss of the epicardial action potential dome
ccurs. Loss of the dome is evidenced by the appearance of
T-segment elevation as seen in lead V1, a manifestation of
he development of transmural voltage gradients during the
lateau of the action potential. It is noteworthy that lead V1
s associated with a negative T-wave, due to delayed
epolarization of epicardium in regions of the RV outflow
ract, where the action potential notch may be accentuated
ut the dome is not lost. Thus, the amplified Tp-e and Tp-e
ispersion are a reflection of TDR secondary to loss of the
P dome in epicardium and the development of an epicar-
ial dispersion of repolarization (19–23). The epicardial
ispersion of repolarization is thought to give rise to phase
re-entry, which provides the closely coupled extrasystole
hat precipitates episodes of rapid polymorphic VT. The VT
ay be maintained initially by circus movement in the RV
able 5. Association Between QTc 460 ms and New
rrhythmic Events
New Events No Events Totals
Tc 460 ms
Yes 6 5 11
No 3 15 18
otals 9 20 29
tatistics: Pearson chi-square p  0.03.igure 2. Kaplan-Meier analysis of arrhythmic events during follow-up
epending on Tpeak-Tend interval (Tp-e) 100 ms or Tp-e 100 ms.
d
dpicardium but is thought to be sustained by transmural
eentry. The TDR provides the substrate that permits the
ntramural reentry.
It is well established that QTc in patients with BS is often
rolonged in the right precordial leads but not in the left
24). This is due to the much more pronounced accentua-
ion of the action potential notch in the RV than in the left
entricular (LV) epicardium. This results in a delayed
econd upstroke, leading to prolongation of the RV epicar-
ial AP, inversion of the T-wave, and prolongation of QTc
n the precordial leads facing this aspect of the heart. A
ore pronounced accentuation of the notch is expected to
ise to a more negative T-wave and longer QT interval and
DR (due to later repolarization of RV epicardium vs.
ndocardium). Our data provide further validation of these
oncepts, demonstrating an association between prolonga-
igure 3. Tpeak-Tend interval (Tp-e) receiver-operating characteristic
ROC) curve. The cut point that better optimizes the values of sensibility
nd specificity are for values 100 ms.
igure 4. Kaplan-Meier analysis of arrhythmic events during follow-up
epending on Tpeak-Tend interval (Tp-e) dispersion 20 ms or Tp-e
ispersion 20 ms.
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May 2, 2006:1828–34 Risk Stratification in the Brugada Syndromeion of QTc in the right precordial leads, TDR, and risk for
evelopment of events.
Although an overlap between BS and long QT syndrome
LQTS) has been described with select mutations (25,26), it
s important to recognize that the prolonged QTc in our
tudy is not consistent with LQTS, because QTc is not
enerally prolonged in lead II or in any of the leads other
han V1 to V3. The LQTS is generally regarded as an LV
isease in which an exaggerated TDR in the LV free wall
nd/or septum provides the principal substrate for the
evelopment of torsades de pointes. In our BS patients,
rolongation of QTc in the right precordial leads is associ-
ted with an increase in TDR in the RV. As with LQTS,
e find that TDR rather than QTc is a better predictor of
rrhythmogenic risk (27).
Assessment of previously asymptomatic BS patients for
isk of sudden death on the basis of inducibility has met
ith considerable debate. Whereas Brugada et al. (28,29)
ave demonstrated PES induction of VT/VF as the most
ensitive predictor of future events, a number of other
nvestigators have failed to demonstrate a statistically sig-
ificant correlation between inducibility and the develop-
ent of a first event (3,30,31). Our results, although limited
n number, support the conclusion of the latter group,
uggesting that PES inducibility is not highly predictive of
he occurrence of sudden cardiac death.
tudy limitations. A number of studies have reported poor
nter- and intraobserver reproducibility of manual measure-
ents of the QT intervals (32–34). This shortfall applies to
he measurement of the Tp-e and Tp-e dispersion as well.
n addition, there has been some confusion as to how to
easure these parameters with different configurations of
he T-wave. This has been clarified in recent experimental
tudies (15), and we applied these methods in our measure-
ents. Another limitation of the study is the relatively small
igure 5. Tpeak-Tend interval (Tp-e) dispersion receiver-operating char-
cteristic (ROC) curve. The cut point that better optimizes the values of
ensibility and specificity are for values 20 ms.umber of observations and limited follow-up period. Con-
1rmation of these results would be desirable in a larger
eries.
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